Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT04251702Completed

Biomarkers of Uterine Muscle Physiology

Role: collaborator

NCT07259629Recruiting

Fasting Induced Hypoglycaemia in Anaesthetised Paediatric Patients

Role: collaborator

NCT05774015Not ApplicableCompleted

Effect of Oral Magnesium Supplementation on Type II Diabetes Mellitus Guided by Serum Ionized Magnesium Level

Role: collaborator

NCT06597240Recruiting

Home Monitoring During Chemoradiation

Role: collaborator

NCT05118074Completed

Nova Max Creatinine and eGFR Meter System

Role: lead

NCT04194476Not ApplicableSuspended

Performance Study of Nova StatStrip® Blood Glucose Monitoring Test System on Neonatal Capillary Blood

Role: lead

NCT05081804Not ApplicableUnknown

The Effect of Enhanced Recovery After Surgery (ERAS) for Cesarean Section on Neonatal Blood Glucose

Role: collaborator

NCT05118061Completed

StatStrip Glucose/Ketone Meter System Ketone Evaluation

Role: lead

NCT05144971Completed

StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation

Role: lead

NCT04096313Completed

Evaluation of the Analytical Performance of ALLEGRO™ Instrument

Role: lead

NCT05118048Terminated

StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood

Role: lead

NCT04035044Completed

Study of the Analytical Performance of ALLEGRO™ Instrument

Role: lead

All 12 trials loaded